Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News
    • Pursuing case for...

    Pursuing case for independent ministry for pharmaceuticals: Ananth Kumar

    Written by savita thakur thakur Published On 2016-08-31T12:10:19+05:30  |  Updated On 31 Aug 2016 12:10 PM IST
    Pursuing case for independent ministry for pharmaceuticals: Ananth Kumar

    New Delhi : Chemicals & Fertilisers Minister H.N. Ananth Kumar said he is pursuing the case for making an independent ministry for pharmaceuticals so that all decisions regarding the industry could be taken under a single roof.


    Speaking at a function here to mark the Foundation Day of the National Pharmaceutical Pricing Authority (NPPA), the minister noted that the pharmaceuticals industry has risen to almost $37 billion and Indian medicines are being exported to over 200 countries.


    "Pharmaceuticals is a sunrise industry and the Government is keen to provide support to it through various means like pharmaceutical parks, medical devices parks, pharmaceutical clusters and promotion of innovation through Atal Innovation Scheme," he said.


    The minister also launched a mobile app developed by NPPA which shows the maximum retail price fixed by NPPA for various scheduled drugs on real time basis.


    The application will be called "Pharma Sahi Daam", Kumar said.


    The minister said that amendments will be made soon to empower NPPA in gathering data and taking appropriate decisions for the drugs included in the NLEM (National List of Essential Medicines).


    The minister advocated a '3A' approach to achieve health security for every citizen of India.


    Universal healthcare can be achieved only by ensuring the availability, affordability and accessibility (3A) of medicines to the common man.


    Under the leadership of Prime Minister Narendra Modi, a two-pronged strategy is being adopted to provide cheap medicines to the common man one is through regulating the prices by NPPA and another is opening of PM Jan Aushadhi Stores, the minister said.


    He said that within one year, 3,000 PM Jan Aushadhi Stores will be opened in the country covering all districts and tehsils.


    Most of the medicines in Jan Aushadhi Stores cost 30 to 40 per cent as compared to the market cost, he said.

    H N Ananth KumarHealthcareIndian medicinesJan Aushadhi StoresNarendra ModiNational Pharmaceutical Pricing AuthorityNPPA
    Source : IANS

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    savita thakur thakur
    savita thakur thakur
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok